PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Ochoa-Rosales, C.* ; Portilla-Fernandez, E.* ; Nano, J. ; Wilson, R. ; Lehne, B.* ; Mishra, P.P.* ; Gao, X.* ; Ghanbari, M.* ; Rueda-Ochoa, O.L.* ; Juvinao-Quintero, D.* ; Loh, M.* ; Zhang, W.* ; Kooner, J.S.* ; Grabe, H.J.* ; Felix, S.B.* ; Schöttker, B.* ; Zhang, Y.* ; Gieger, C. ; Müller-Nurasyid, M. ; Heier, M. ; Peters, A. ; Lehtimäki, T.* ; Teumer, A.* ; Brenner, H.* ; Waldenberger, M. ; Ikram, M.A.* ; van Meurs, J.B.J.* ; Franco, O.H.* ; Voortman, T.* ; Stricker, B.H.* ; Muka, T.*

Epigenetic link between statin therapy and type 2 diabetes.

Diabetes Care 43, 875-884 (2020)
Publ. Version/Full Text Research data DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
OBJECTIVE To investigate the role of epigenetics in statins' diabetogenic effect comparing DNA methylation (DNAm) between statin users and nonusers in an epigenome-wide association study in blood. RESEARCH DESIGN AND METHODS Five cohort studies' participants (n = 8,270) were classified as statin users when they were on statin therapy at the time of DNAm assessment with Illumina 450K or EPIC array or noncurrent users otherwise. Associations of DNAm with various outcomes like incident type 2 diabetes, plasma glucose, insulin, and insulin resistance (HOMA of insulin resistance [HOMA-IR]) as well as with gene expression were investigated. RESULTS Discovery (n = 6,820) and replication (n = 1,450) phases associated five DNAm sites with statin use: cg17901584 (1.12 x 10(-25) [DHCR24]), cg10177197 (3.94 x 10(-08) [DHCR24]), cg06500161 (2.67 x 10(-23) [ABCG1]), cg27243685 (6.01 x 10(-09) [ABCG1]), and cg05119988 (7.26 x 10(-12) [SC4MOL]). Two sites were associated with at least one glycemic trait or type 2 diabetes. Higher cg06500161 methylation was associated with higher fasting glucose, insulin, HOMA-IR, and type 2 diabetes (odds ratio 1.34 [95% CI 1.22, 1.47]). Mediation analyses suggested that ABCG1 methylation partially mediates the effect of statins on high insulin and HOMA-IR. Gene expression analyses showed that statin exposure and ABCG1 methylation were associated with ABCG1 downregulation, suggesting epigenetic regulation of ABCG1 expression. Further, outcomes insulin and HOMA-IR were significantly associated with ABCG1 expression. CONCLUSIONS This study sheds light on potential mechanisms linking statins with type 2 diabetes risk, providing evidence on DNAm partially mediating statins' effects on insulin traits. Further efforts shall disentangle the molecular mechanisms through which statins may induce DNAm changes, potentially leading to ABCG1 epigenetic regulation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
16.019
4.581
14
22
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Cardiovascular-disease Prevention; Dna Methylation; Cellular Cholesterol; European Guidelines; Ldl-cholesterol; Increased Risk; Abcg1; Desmosterolosis; Identification; Metaanalysis
Language english
Publication Year 2020
HGF-reported in Year 2020
ISSN (print) / ISBN 0149-5992
e-ISSN 1935-5548
Journal Diabetes Care
Quellenangaben Volume: 43, Issue: 4, Pages: 875-884 Article Number: , Supplement: ,
Publisher American Diabetes Association
Publishing Place Alexandria, Va.
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
Institute of Genetic Epidemiology (IGE)
POF-Topic(s) 30202 - Environmental Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Research field(s) Genetics and Epidemiology
PSP Element(s) G-504000-002
G-504091-001
G-504100-001
G-504000-006
G-504090-001
DOI 10.2337/dc19-1828
WOS ID WOS:000521985600031
Scopus ID 85082147382
PubMed ID 32033992
Erfassungsdatum 2020-03-23
[➜Report correction]